A new cell-based assay to evaluate myogenesis in mouse myoblast C2C12 cells

Sayer, 2013, New horizons in the pathogenesis, diagnosis and management of sarcopenia, Age Ageing, 42, 145, 10.1093/ageing/afs191 Yamada, 2013, Prevalence of sarcopenia in community-dwelling Japanese older adults, J. Am. Med. Dir. Assoc., 14, 911, 10.1016/j.jamda.2013.08.015 Johns, 2013, Muscle wasting in cancer, Int. J. Biochem. Cell Biol., 45, 2215, 10.1016/j.biocel.2013.05.032 Rinaldi, 2014, Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks, Transl. Res., 163, 409, 10.1016/j.trsl.2013.11.006 Silberstein, 1986, Developmental progression of myosin gene expression in cultured muscle cells, Cell, 46, 1075, 10.1016/0092-8674(86)90707-5 Yang, 2014, Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model, Mol. Cell. Biol., 34, 1607, 10.1128/MCB.01346-13 Kanai, 2000, TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins, EMBO J., 19, 6778, 10.1093/emboj/19.24.6778 Ozawa, 2006, Designing split reporter proteins for analytical tools, Anal. Chim. Acta, 556, 58, 10.1016/j.aca.2005.06.026 Ozawa, 2009, Protein reconstitution methods for visualizing biomolecular function in living cells, Yakugaku Zasshi, 129, 289, 10.1248/yakushi.129.289 Cabantous, 2005, Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein, Nat. Biotechnol., 23, 102, 10.1038/nbt1044 Sudol, 1994, Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product, Oncogene, 9, 2145 Watt, 2010, Yap is a novel regulator of C2C12 myogenesis, Biochem. Biophys. Res. Commun., 393, 619, 10.1016/j.bbrc.2010.02.034 Bao, 2011, A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription, J. Biochem., 150, 199, 10.1093/jb/mvr063 Ozawa, 2007, A minimal peptide sequence that targets fluorescent and functional proteins into the mitochondrial intermembrane space, ACS Chem. Biol., 2, 176, 10.1021/cb600492a Ozawa, 2005, A high-throughput screening of genes that encode proteins transported into the endoplasmic reticulum in mammalian cells, Nucleic Acids Res., 33, e34, 10.1093/nar/gni032 Oudman, 2013, The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review, PLoS One, 8, e52879, 10.1371/journal.pone.0052879 Semsarian, 1999, Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model, Biochem. J., 339, 443, 10.1042/bj3390443 Hochreiter-Hufford, 2013, Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion, Nature, 497, 263, 10.1038/nature12135 Chen, 2007, Cell–cell fusion, FEBS Lett., 581, 2181, 10.1016/j.febslet.2007.03.033 Moore, 2007, A role for the Myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion, Development, 134, 3145, 10.1242/dev.001214 Pajcini, 2008, Myoblasts and macrophages share molecular components that contribute to cell–cell fusion, J. Cell Biol., 180, 1005, 10.1083/jcb.200707191 Foletta, 2011, The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy, Pflug. Arch., 461, 325, 10.1007/s00424-010-0919-9 Sanchez, 2014, FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis, Cell. Mol. Life Sci., 71, 1657, 10.1007/s00018-013-1513-z